How can you allocate brand marketing budgets and predict return before you have launched?

Pre-Launch Pressure

Under pressure to deliver even higher profits from pharmaceutical brand launches? Faced with legal, aggressive generic competitors? Limited by the shorter time life cycle of todays pharmaceutical brands? How can you really know what pharmaceutical marketing activities will provide what return before even launching your product?

Pre-Launch Questions

Preparation time for launching a new pharmaceutical brand usually starts with a market assessment about 10 years before. The closer the launch gets, the more questions need to be asked, such as:
• Have we positioned the drug the best we can?
• Will our messages give us maximum benefit?
• How much market share should we have at launch versus competitors?
• How will we know what competitor weaknesses we can exploit?
• What are our optimal sales and marketing activities for maximum growth?
• Have we done everything right?

Pre-Launch Answers

Discover the answers to these questions and more, by using Eularis 94.8 Pre-launch Analytics for predicting and planning your pharmaceutical brand marketing. Pre-launch Analytics is part of the advanced, 94.8 Analytics system from Eularis, and can help you to:
• Quantify the potential impact from each marketing activity before launch
• Evaluate which messages will have the most impact on actual prescribing
• Reveal how, when and where to spend your budget for the best results
• Forecast brand performance at launch based on the current situation
• Get a 'What If' forecast showing the impact of any specific marketing changes.

Ideal Analytics Users

Recognize yourself below? If so, the 94.8 Pre-launch Analytics system would be ideal for your pharmaceutical marketing needs:
• VP Sales and Marketing
• Sales and Marketing Directors
• Commercial Directors
• Business Unit Managers
• Business Analytics Managers
• Business Intelligence Managers
• Group Brand Managers
• Senior Product Managers
• Senior Brand Managers
• Agency Directors needing to show ROI to their pharma brand clients.

Client Quotes

Powerful stuff. In my 20 years of marketing I have never seen such valuable data on my drug brands.' Specialist Team Leader, Pfizer

'It provides a level of insight which has been difficult to obtain using existing tools. The team were impressed by its ability to predict market share movements based on mix investment decisions.' Brand Manager, GlaxoSmithKline

'It actually does what it says on the tin.' Business Intelligence Manager, Boehringer Ingelheim.

'Your system allowed us all to fully understand just how our overall company and its brands were perceived versus our competitors and what we were required to do in order to grow. Importantly, having a tool available that allowed us to predict whether or not our market share would grow or decline was invaluable as it allowed us for the first time to realistically evaluate our efforts and investments.' CEO, AstraZeneca

'We always had the problem that we had a lot of data but it still required guesswork and gut feeling to get us to our strategic marketing decisions. I wasn't sure you would be able to show me more than I already knew. However, this workshop really showed me how to connect the data and the decisions and we have now got repeatable improving sales results from implementing this!' Attendee from Eularis Workshop on ROI

CONTACT US TODAY FOR INFORMATION ON PRE LAUNCH MARKETING ANALYTICS.

CONTACT US TODAY FOR ANY FURTHER INFORMATION ON ANY ASPECT OR TO SCHEDULE A MEETING FOR A DEMONSTRATION.